日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

An in vitro approach for simulating divergent Golgi O-glycosylation of tumor-associated MUC1 from normal MUC1

一种模拟肿瘤相关MUC1与正常MUC1高尔基体O-糖基化差异的体外方法

Nashed, Abdullateef; Dilsook, Kyllen; Senapathi, Tharindu; Naidoo, Kevin J

Retraction Note: LINC01296/miR-26a/GALNT3 axis contributes to colorectal cancer progression by regulating O-glycosylated MUC1 via PI3K/AKT pathway

撤稿声明:LINC01296/miR-26a/GALNT3轴通过PI3K/AKT通路调控O-糖基化MUC1,从而促进结直肠癌的进展。

Liu, Bing; Pan, Shimeng; Xiao, Yang; Liu, Qianqian; Xu, Jingchao; Jia, Li

Bioresponsive PDA-GelMA hydrogel microspheres coordinate redox-immune homeostasis via controlled rhMUC13 delivery for radiation-induced intestinal injury

生物响应性PDA-GelMA水凝胶微球通过控制rhMUC13的递送来协调氧化还原免疫稳态,从而治疗辐射引起的肠道损伤。

Ling, Zhi; Zhuang, Jinqiang; Wang, Mingyan; Lin, Xi; Zhu, Yefei; Liu, Xinyi; Ding, Zifan; Liu, Qingxie; Gong, Weijuan; Lu, Guotao; Yin, Xudong; Sun, Yunfeng; Wang, Zhihao; Wang, Yaodong

Evolution of the MUC1 gene in eutherian mammals as an adaptation responsible for the increasing incidence of cancer in humans

真兽类哺乳动物中MUC1基因的进化是一种适应性进化,也是导致人类癌症发病率上升的原因之一。

Kufe, Donald W

DS-3939a: A TA-MUC1-Directed Antibody-Drug Conjugate with Broad Antitumor Activity

DS-3939a:一种靶向TA-MUC1的抗体-药物偶联物,具有广谱抗肿瘤活性

Takano, Kohei; Yukiura, Mayuko; Takahashi, Kazuki; Kitamura, Michiko; Okuno, Hiroko; Shiose, Yoshinobu; Honda, Kokichi; Oyama, Kazunori; Yamada, Makiko; Obuchi, Wataru; Kumagai, Kazuyoshi; Sakurai, Ken; Goto, Riki; Zembutsu, Akiko; Kagari, Takashi; Abe, Yuki; Agatsuma, Toshinori

Chemoradiotherapy facilitates siglec-10(+)/siglec-9(+) macrophage-mediated impairment of CD24(+)/MUC16(+) tumor cell elimination and enhances PD-L2 dependent immunosuppression in cervical cancer

放化疗促进 Siglec-10(+)/Siglec-9(+) 巨噬细胞介导的 CD24(+)/MUC16(+) 肿瘤细胞清除受损,并增强宫颈癌中 PD-L2 依赖性免疫抑制。

Kong, Wenzhi; Liu, Penglin; Zhang, Jiamin; Liu, Qun; Deng, Mengqi; Xu, Chunyu; He, Junqi; Miao, Jinwei

[Expression of Concern] MUC1 is a downstream target of STAT3 and regulates lung cancer cell survival and invasion

【关注事项】MUC1是STAT3的下游靶点,调控肺癌细胞的存活和侵袭。

Gao, Jingchun; Mcconnell, Matthew J; Yu, Bin; Li, Jiannong; Balko, Justin M; Black, Esther P; Johnson, Joseph O; Lloyd, Mark C; Altiok, Soner; Haura, Eric B

Tumour-Associated MUC1 Exerts Multiple Effects on Cholesterol and Lipid Metabolism-A Potential Pathogenic Effector of Atherosclerosis in Cancer

肿瘤相关MUC1对胆固醇和脂质代谢具有多种影响——癌症动脉粥样硬化的潜在致病效应因子

Chen, Yunliang; Scully, Michael

Retraction: Rhodomyrtus tomentosa as a new anticancer molecular strategy in breast histology via Her2, IL33, EGFR, and MUC1

撤稿声明:桃金娘(Rhodomyrtus tomentosa)作为一种新的抗癌分子策略,通过 Her2、IL33、EGFR 和 MUC1 靶向治疗乳腺组织学中的癌症

MUC16 promotes endometrial cancer progression and modulates sensitivity to lapatinib through the ESR1/PI3K/AKT axis

MUC16通过ESR1/PI3K/AKT通路促进子宫内膜癌进展并调节其对拉帕替尼的敏感性。

Yu, Yan; Lv, Shuqing; Li, Guanlong; Sun, Lingna; Su, Shan